Covid-19 vaccination has been recommended during pregnancy because pregnant women with coronavirus disease are at increased risk for adverse outcomes.


According to the New England Journal of Medicine, safety data on Covid-19 vaccination during pregnancy remains limited, and the following case controlled study with data from Norwegian registries on first-trimester pregnancies, Covid-19 vaccination, background characteristics, and underlying health conditions conducted:




“We identified all women who were registered between February 15 and August 15, 2021, as having had a miscarriage before 14 weeks of gestation (case patients) and those with a primary care–based confirmation of ongoing pregnancy in the first trimester (controls).


In Norway, although vaccination during the first trimester is not recommended except in women with underlying risk conditions, women not yet aware that they were pregnant may still be vaccinated in the first trimester.


We estimated odds ratios with 95% confidence intervals for Covid-19 vaccination within 5-week and 3-week windows before a miscarriage or ongoing pregnancy, adjusting for women’s age, country of birth, marital status, educational level, household income, number of children, employment in a health care profession, underlying risk conditions for Covid-19, previous test positive for severe acute respiratory syndrome coronavirus 2, and calendar month.


Among 13,956 women with ongoing pregnancies (of whom 5.5% were vaccinated) and 4521 women with miscarriages (of whom 5.1% were vaccinated), the median number of days between vaccination and miscarriage or confirmation of ongoing pregnancy was 19.


Among women with miscarriages, the adjusted odds ratios for Covid-19 vaccination were 0.91 (95% confidence interval [CI], 0.75 to 1.10) for vaccination in the previous 3 weeks and 0.81 (95% CI, 0.69 to 0.95) for vaccination in the previous 5 weeks.


The results were similar in an analysis that included all available vaccine types, in an analysis stratified according to the number of doses received (one or two), and in sensitivity analyses limited to health care personnel (for whom vaccination was routinely recommended other than in the first trimester) or women with at least 8 weeks of follow-up after confirmed pregnancy (to exclude subsequent pregnancy loss).


A limitation of our report is that the registry lacks information on gestational age at the time of early pregnancy registration, and thus we could not match case patients and controls according to gestational age.


However, most recognized miscarriages are known to occur between pregnancy weeks 6 and 10,5 a period that is similar to the gestational ages at which women in Norway consult a physician to confirm pregnancy. Also, only approximately 40% of women in Norway have a primary care appointment to confirm pregnancy, but the characteristics of these women appear to be similar to those of women who do not have a registered pregnancy confirmation.


We cannot address associations between vaccination and miscarriages that were not clinically recognized. Although adjustment for potential confounders had minimal effect on our results, the registry does not include information on lifestyle and other factors that might confound our findings. Our study found no evidence of an increased risk for early pregnancy loss after Covid-19 vaccination and adds to the findings from other re – ports supporting Covid-19 vaccination during pregnancy.”


Read the full article here: Covid19 Vaccination